Chronic hepatitis E in patients with indolent lymphoma after treatment with rituximab and bendamustine

Hepatology. 2018 Jun;67(6):2468-2470. doi: 10.1002/hep.29697. Epub 2018 Apr 19.
No abstract available

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Aged, 80 and over
  • Antineoplastic Agents, Alkylating / administration & dosage*
  • Antineoplastic Agents, Immunological / administration & dosage*
  • Bendamustine Hydrochloride / administration & dosage*
  • Chronic Disease
  • Drug Combinations
  • Fatal Outcome
  • Female
  • Hepatitis E / complications*
  • Humans
  • Lymphoma, Follicular / complications*
  • Lymphoma, Follicular / drug therapy*
  • Rituximab / administration & dosage*

Substances

  • Antineoplastic Agents, Alkylating
  • Antineoplastic Agents, Immunological
  • Drug Combinations
  • Rituximab
  • Bendamustine Hydrochloride